We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,786

Life sciences: product regulation and liability in Turkey
  • NSN Law Firm
  • Turkey, Global
  • April 13 2018

A structured guide to product regulation and liability laws in Turkey


FDA Issues Refusal-to-File Letter to Alkermes for Depression Treatment
  • Knobbe Martens
  • USA
  • April 9 2018

On April 2, 2018, Irish biotech Alkermes revealed that it had received a Refusal-to-File letter from the FDA regarding its depression drug ALKS 5461


Agricultural biotechnology: a veritable tool for economic diversification in Nigeria
  • George Etomi & Partners
  • Nigeria
  • April 2 2018

The drastic fall of oil prices in the international market has spurred the Federal Government to diversify the Nigerian economy into other sources of


An Easier Road to a Hong Kong Listing for Biotech Companies
  • Morrison & Foerster LLP
  • Hong Kong
  • March 28 2018

In June 2017, the Hong Kong Stock Exchange (“HKEx”) initiated a holistic review of the Hong Kong listing regime to enhance its overall competitiveness


Biotech Deals Targeted for More Scrutiny in New Trump Administration Trade Report
  • Morgan Lewis & Bockius LLP
  • USA
  • March 27 2018

The biotech industry, now designated as a technology and innovation-related area of special concern to the protection of the US industrial and


Washington Healthcare Update - Mar 19, 2018
  • McGuireWoods LLP
  • USA
  • March 19 2018

The House had planned to take up the Omnibus spending bill the week of the 12th in order to give the Senate plenty of time to consider the bill


Hong Kong Stock Exchange consults on detailed rules of a new listing regime for biotech and innovative companies
  • Deacons
  • Hong Kong
  • March 5 2018

Following the release of the New Board Concept Paper Conclusions on 15 December 2017, The Stock Exchange of Hong Kong Limited (the “Exchange”


Hong Kong Announces Groundbreaking New Rules for Dual-Class Share, High-Tech and Biotech Company Listings
  • Skadden Arps Slate Meagher & Flom LLP
  • Hong Kong
  • February 26 2018

After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23


CRISPR: The New Frontier of Biotechnology Innovation
  • Paul Hastings LLP
  • USA
  • February 22 2018

By now, life sciences IP attorneys have probably heard about clustered regularly interspaced short palindromic repeats. In short, they are the


Patentability in Poland
  • Bird & Bird
  • Poland, Global
  • February 19 2018

An overview of patentability in Poland